Kensington Investment Counsel’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
VCM
VPM
Kensington Investment Counsel's MRK Position: Q1 2026 in Review
Kensington Investment Counsel increased its Merck (MRK) stake by 2.3% in Q1 2026, buying an estimated $101K and bringing the position to 39,225 shares worth $4.72M. The position accounts for 2.27% of the portfolio, ranked #17.
Kensington Investment Counsel first reported a position in MRK in Q4 2020 and has held it in 21 quarters since. The position peaked at $4.8M in Q1 2024. 3,783 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Kensington Investment Counsel held 39,225 shares of Merck worth $4.72M as of Q1 2026.
- Kensington Investment Counsel bought 879 Merck shares in Q1 2026, an estimated $101K.
- Merck made up 2.27% of Kensington Investment Counsel's portfolio in Q1 2026, its #17 holding.
- Kensington Investment Counsel first reported a position in Merck in Q4 2020 and has held it in 21 quarters since.
- Kensington Investment Counsel's Merck position peaked at $4.8M in Q1 2024.
- 3,783 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Kensington Investment Counsel's 13F filing for Q1 2026, filed 19 May 2026.